What is Pentara?
Pentara operates as a comprehensive clinical research organization, offering end-to-end services that span study design, clinical programming, data management, biostatistics, statistical consulting, medical writing, and regulatory support. Established in 2001, the company has built a strong reputation for its statistical expertise and its unwavering commitment to ensuring the integrity and quality of clinical trial data. Pentara's core mission is to deliver meaningful insights that expedite the development of effective treatments for neurodegenerative diseases, positioning itself as a key partner for pharmaceutical and biotechnology firms.
How much funding has Pentara raised?
Pentara has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Pentara?
With its substantial late-stage funding, Pentara is strategically positioned to enhance its service offerings and expand its operational capacity. The recent major strategic investment will likely fuel further innovation in its data management and analytical capabilities, enabling deeper insights into complex neurodegenerative disease pathways. This capital infusion is expected to accelerate Pentara's growth, allowing it to take on larger, more complex clinical trials and solidify its leadership in supporting the development of novel therapies for conditions such as Alzheimer's. The company's continued focus on quality and statistical rigor will be paramount as it navigates this expansion phase.
See full Pentara company page
